110019 ⎘
dsDNA viruses; Details; Poxviridae; Orthopoxvirus, e.g. vaccinia virus, variola Use of virus, viral particle or viral elements as a vector
Sub-classes:REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MARBURG VIRUS GLYCOPROTEIN (GP) AND MATRIX PROTEIN (VP40)
#2Replication-deficient modified vaccinia Ankara (MVA) expressing glycoprotein (GP) and matrix protein (VP40)
#3Chimpanzee adenoviral vector-based filovirus vaccines
#4Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus
#5Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40)
#6Methods and compositions for sustained immunotherapy
#7Stable recombinant MVA vectors comprising modified RSV genes with reduced intramolecular recombinatorial activity
#8Soluble Forms of Hendra and Nipah Virus G Glycoprotein
#9Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof
#10Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#11COMPOSITION AND USES THEREOF
#12Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
#13Soluble forms of Hendra and Nipah virus G glycoprotein
#14Fusion of heterooligomeric mycobacterial antigens
#15Composition and uses thereof
#16Treatment and prevention of malaria
#17Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus
#18Crimean-congo haemorrhagic fever virus antigenic composition
#19Soluble forms of hendra and nipah virus G glycoprotein
#20Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#21Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#22Methods and compositions for sustained immunotherapy
#23Compositions, methods and uses for expression of enterobacterium-associated peptides
#24Adjuvanted rabies vaccine with improved viscosity profile
#25Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#26Vector comprising multiple homologous nucleotide sequences
#27Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes
#28Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#29Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#30Methods for attenuating virus strains for diagnostic and therapeutic uses
#31Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#32Soluble forms of Hendra and Nipah virus G glycoprotein